Journal scan
Morning sickness drug is not linked to increased risk of birth defects
A new study has found no evidence of a link between anti-nausea drug Zofran, also known as ondansetron, to an increased risk of having a child with birth defects.
Nursing Standard is published by RCNi, the publishing company of the Royal College of Nursing.